199 related articles for article (PubMed ID: 7270052)
1. [L-dopa-resistant Parkinson's disease with cerebral atrophy: striato-nigral degeneration?].
Dell'Aria V; Ciannella L; Melone MA
Acta Neurol Quad (Napoli); 1981; 42():212-5. PubMed ID: 7270052
[No Abstract] [Full Text] [Related]
2. [L-dopa-resistant parkinsonism with cerebral atrophy: striato-nigral degeneration? 2 cases].
Dell'Aria V; Ciannella L; Melone MA
Acta Neurol (Napoli); 1981 Feb; 3(1):212-5. PubMed ID: 7246294
[No Abstract] [Full Text] [Related]
3. [Striato-nigral degeneration. Clinical and anatomic study of a case which responded favorably to L-Dopa].
Feve JR; Mussini JM; Mathé JF; Cler JM; Nomballais MF
Rev Neurol (Paris); 1977 Apr; 133(4):271-8. PubMed ID: 929031
[TBL] [Abstract][Full Text] [Related]
4. [Striato-nigral degeneration. Apropos of a clinical, therapeutic, and anatomic study of 2 cases].
Boudin G; Guillard A; Mikol J; Galle P
Rev Neurol (Paris); 1976 Feb; 132(2):137-56. PubMed ID: 973069
[TBL] [Abstract][Full Text] [Related]
5. [Striato-nigral degeneration. A propos of 2 anatomo-clinical cases].
Michel D; Tommasi M; Laurent B; Trillet M; Schott B
Rev Neurol (Paris); 1976 Jan; 132(1):3-22. PubMed ID: 968312
[TBL] [Abstract][Full Text] [Related]
6. A case of late onset striatonigral degeneration.
Przedborski S; Schiffmann SN; Monseu G; Maloteaux JM; Flament-Durand J
Acta Neurol Belg; 1989; 89(1):29-37. PubMed ID: 2508411
[TBL] [Abstract][Full Text] [Related]
7. L-dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain.
Cooper JM; Daniel SE; Marsden CD; Schapira AH
Mov Disord; 1995 May; 10(3):295-7. PubMed ID: 7651446
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic Parkinson's disease combined with multiple system atrophy. A clinicopathological report.
Hughes AJ; Daniel SE; Lees AJ
Mov Disord; 1991; 6(4):342-6. PubMed ID: 1758453
[TBL] [Abstract][Full Text] [Related]
9. [Autopsy case of cortico-striato-pallido-nigral degeneration associated with neuronal achromasia].
Maeda S; Takahashi S; Isaka K; Aihara Y; Fujita T
Rinsho Shinkeigaku; 1977 Feb; 17(2):61-6. PubMed ID: 558851
[No Abstract] [Full Text] [Related]
10. [Pallido-nigral degeneration--a case of Parkinson's syndrome resistant to L-dopa].
Matsuoka Y; Muroga T; Wakayama Y; Sugimura K; Matsui T
Rinsho Shinkeigaku; 1977 Jan; 17(1):46-51. PubMed ID: 557400
[No Abstract] [Full Text] [Related]
11. [Analysis of a therapeutic failure of L-Dopa: can Adams-Van Bosaert and Van Der Eecken's strio-nigral degeneration be diagnosed during the patient's life?].
André JM; Royer RJ; Duc M; Kissel P
Rev Neurol (Paris); 1974; 130(7-8):322-6. PubMed ID: 4453761
[No Abstract] [Full Text] [Related]
12. [Rare extrapyramidal disorders: progressive supranuclear paralysis and striato-nigral degeneration].
Marttila R; Kalimo H; Nikoskelainen E; Rinne UK
Duodecim; 1982; 98(3):191-200. PubMed ID: 7060514
[No Abstract] [Full Text] [Related]
13. Interactions of exogenous L-dopa with nigrostriatal dopaminergic neurons in Parkinson's disease.
Melamed E
Adv Neurol; 1990; 53():61-6. PubMed ID: 2173376
[No Abstract] [Full Text] [Related]
14. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
Carlsson T; Carta M; Muñoz A; Mattsson B; Winkler C; Kirik D; Björklund A
Brain; 2009 Feb; 132(Pt 2):319-35. PubMed ID: 19039008
[TBL] [Abstract][Full Text] [Related]
15. [Type of familial extrapyramidal disease--cortico-striato-pallido-nigral degeneration (author's transl)].
Maeda S; Yokoi S; Isaka K; Numabe T
Seishin Shinkeigaku Zasshi; 1973 Oct; 75(10):657-72. PubMed ID: 4798818
[No Abstract] [Full Text] [Related]
16. Neuropathology of Parkinson's disease and related syndromes.
Gibb WR
Neurol Clin; 1992 May; 10(2):361-76. PubMed ID: 1584179
[TBL] [Abstract][Full Text] [Related]
17. Degeneration of the centré median-parafascicular complex in Parkinson's disease.
Henderson JM; Carpenter K; Cartwright H; Halliday GM
Ann Neurol; 2000 Mar; 47(3):345-52. PubMed ID: 10716254
[TBL] [Abstract][Full Text] [Related]
18. Role of the nigrostriatal dopaminergic neurons in mediating the effect of exogenous L-dopa in Parkinson's disease.
Melamed E
Mt Sinai J Med; 1988 Jan; 55(1):35-42. PubMed ID: 3279303
[No Abstract] [Full Text] [Related]
19. [A case at Salpêtrière hospital November 1990. Parkinson syndrome with poor response to dopa therapy in a 64 year-old man].
Dubas F; Vidailhet M; Henin D
Rev Neurol (Paris); 1992; 148(8-9):580-5. PubMed ID: 1494735
[No Abstract] [Full Text] [Related]
20. Mitochondrial respiratory chain function in multiple system atrophy.
Gu M; Gash MT; Cooper JM; Wenning GK; Daniel SE; Quinn NP; Marsden CD; Schapira AH
Mov Disord; 1997 May; 12(3):418-22. PubMed ID: 9159739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
